NovoLINC
PrivateLast Round
Seed
Dec 18, 2025
Total Funding Raised
$12.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NovoLINC is a nanotechnology and manufacturing company that develops advanced thermal interface material solutions for high-performance computing.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Semiconductors, Computing Hardware
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovoLINC Comparables
Compare NovoLINC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arieca Inc. | 86% | |
| Carbice | 80% | |
| Boston Materials | 77% |
NovoLINC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 18, 2025 | ||||
| Seed | Jan 21, 2025 |
NovoLINC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HV Fund | Seed |
| Carnegie Mellon University Investment Office | Seed |
| M Ventures | Seed |
| Foothill Ventures | Seed |
| TDK Ventures | Seed |
| Fathom Fund | Seed |
| M Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 17% QoQ, from 18 to 21 employees.
- Jul 28, 2026
Grew 29% QoQ, from 17 to 22 employees.
Recent news
Latest coverage and updates
- expands_facilitiesSep 18, 2026
NovoLINC expands facilities to Pennsylvania, United States, Northern America, Americas.
- launchesSep 17, 2026
NovoLINC launched MaxLINC on Sep 17th '26.
- expands_facilitiesSep 17, 2026
NovoLINC expanded facilities to Pennsylvania, United States, Northern America, Americas on Sep 19th '26.
NovoLINC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NovoLINC's valuation, stock price, and market status.
Is NovoLINC a public or private company?
NovoLINC is a private company.
What is the current stock price of NovoLINC?
NovoLINC is a private company, so its shares have no public market price. Caplight tracks NovoLINC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NovoLINC worth (valuation)?
Valuation information for NovoLINC is not publicly available.
Can I buy NovoLINC stock?
NovoLINC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NovoLINC's last funding round?
NovoLINC's most recent funding round was Seed on December 18, 2025.
Who are the main investors in NovoLINC?
Key investors in NovoLINC include M Ventures, TDK Ventures, Fathom Fund, M Ventures.
Will NovoLINC IPO soon?
No public IPO plans have been announced for NovoLINC.
How can I track NovoLINC secondary market activity?
Caplight tracks bids, offers, and trades in NovoLINC's shares on secondary markets.